Ask AI
ProCE Banner Activity

Clinical Benchmarking in Psoriasis and Obesity: Are You Aligned With the Experts?

Slideset

Better understand the bidirectional relationship between psoriasis and obesity, including how obesity negatively affects treatment efficacy and quality of life in patients with psoriasis. Use these downloadable slides to gain expert insights on integrating obesity screening, assessment, and management in comprehensive psoriasis care that prioritizes compassionate, patient-centered communication and the latest evidence on novel obesity medications.

Released: October 20, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with the Group for Research and Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA).

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Group for Research And Assessment for Psoriasis and Psoriatic Arthritis (GRAPPA)

ProCE Banner

Target Audience

The proposed educational program is intended for dermatologists in France, Germany, Italy, Spain, and the United States who manage patients with psoriasis.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Incorporate evidence for the bidirectional relationship between PsO and obesity into clinical management decisions to improve treatment outcomes and quality of life in patients with both conditions

  • Execute evidence-based obesity screening and management practices according to local guideline and access realities in patients with PsO

  • Employ collaborative, compassionate, and culturally sensitive strategies to discuss obesity management and treatment expectations with patients